Weekly insights for industry insiders, capital allocators, policy researchers, and anyone who wants to understand the business and economics of the global plasma industry.
Mar 26, 2026
FDA's staffing crisis has been well documented for drug developers. For the independent operators now carrying plasma's collection growth, the exposure is more specific, less visible, and not yet in any model.
Mar 17, 2026
The Egypt Unlock: Grifols just proved that a compensated, non-Western plasma platform can clear the EMA bar.
